Respiratory Disease

Patients with sniffles because of allergic conditions have different living fungi within their noses compared with healthy people, according to a study conducted in Portugal and published in Frontiers in Microbiology.

In a nonoccupational setting, low ambient benzene exposure over a year was linked to a heightened mortality risk, according to results published in American Journal of Respiratory and Critical Care Medicine.

Each cover of Healio | Infectious Disease News is topped by a feature story on an emerging topic in the field of ID.

Respiratory syncytial virus vaccines proved highly effective at preventing hospitalization and ED visits in older adults, even in those with immunocompromising conditions, results from an observational analysis showed.

The risk for respiratory-related ED visits in New York was greater on days with both thunderstorms and power outages vs. days with only one of these events, according to results published in Environmental Health Perspectives.

We are currently experiencing a renaissance in the treatment landscape for respiratory disease, but we can do better.

In late May, the FDA announced approval of Moderna's mResvia, marking the third vaccine approved for respiratory syncytial virus and first time messenger RNA technology has been used for preventing a disease other than COVID-19.

One of the biggest issues particularly impacting patients with respiratory diseases is climate change.

Rural unincorporated colonias in the U.S.-Mexico borderlands have limited access to health care, showing that geography is a determinant of health in low-income communities, according to a study published in Social Science & Medicine.

Cases of multisystem inflammatory syndrome in children increased by nearly two-thirds last fall, aligning with an increase in COVID-19 activity, according to a study published in MMWR.